CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Phase II Study of Weekly Paclitaxel Plus Gemcitabine as a Second-Line Therapy in Patients with Metastatic or Recurrent Small Cell Lung Cancer
Tak Yun, Heung Tae Kim, Ji-Youn Han, Sung Jin Yoon, Hyae Young Kim, Byung-Ho Nam, Jin Soo Lee
Cancer Research and Treatment. 2016;48(2):465-472.   Published online 2015 May 26    DOI: https://doi.org/10.4143/crt.2015.061

Excel Download

147PD A PHASE II STUDY OF WEEKLY PACLITAXEL PLUS GEMCITABINE AS SECOND-LINE THERAPY IN PATIENTS WITH METASTATIC OR RECURRENT SMALL CELL LUNG CANCER (SCLC)
Lung Cancer. 2009;64:S62   Crossref logo
Link1 Link2

A Phase II Study of Weekly Paclitaxel Plus Gemcitabine as a Second-Line Therapy in Patients with Metastatic or Recurrent Small Cell Lung Cancer
Cancer Research and Treatment. 2016;48(2):465-472   Crossref logo
Link1 Link2 Link3

33 Weekly paclitaxel in second line métastatic non-small-cell lung cancer
Lung Cancer. 2003;41:S282   Crossref logo
Link1 Link2

P-585 Carboplatin plus gemcitabine followed by weekly paclitaxel inadvanced and metastatic non-small cell lung cancer (NSCLC): A phase II study
Lung Cancer. 2005;49:S272   Crossref logo
Link1 Link2

A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer
Chemotherapy. 2012;58(1):78-83   Crossref logo
Link1 Link2

A phase II study testing weekly platinum derivative combination chemotherapy as second-line treatment in patients with advanced small cell lung cancer
Lung Cancer. 1995;12(3):277   Crossref logo
Link1 Link2

Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer
Lung Cancer. 2004;44(2):231-239   Crossref logo
Link1 Link2

Phase II trial of gemcitabine as second line therapy for non-small cell lung cancer (NSCLC)
Lung Cancer. 1998;21:S49   Crossref logo
Link1 Link2

A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trial
BMC Cancer. 2015;15(1):   Crossref logo
Link1 Link2 Link3

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer
Lung Cancer. 1995;12(1-2):152   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.